Truncated prolyl oligopeptidase from Pyrococcus furiosus

Proteins: Structure, Function and Genetics

Volumn 69, Issue 3, 2007, Pages 633-643

  Juhász, Tünde ^a   Szeltner, Zoltán ^a   Polgár, László ^a  

^a INSTITUTE OF EXPERIMENTAL MEDICINE   (Hungary)

Author keywords

Kinetic analysis; Protein stability; Refolding; Site specific mutagenesis; Thermophilic enzyme

Indexed keywords

GUANIDINE; PEPTIDASE; PROLYL ENDOPEPTIDASE;

AMINO ACID SEQUENCE; AMINO TERMINAL SEQUENCE; ARTICLE; CATALYSIS; CATALYST; CIRCULAR DICHROISM; DIFFERENTIAL SCANNING CALORIMETRY; ENZYME ACTIVATION; ENZYME ACTIVE SITE; ENZYME ACTIVITY; ENZYME DENATURATION; ENZYME STABILITY; ENZYME SUBSTRATE COMPLEX; KINETICS; NONHUMAN; PARAMETER; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN FOLDING; PYROCOCCUS FURIOSUS; REACTION ANALYSIS; SEQUENCE ANALYSIS; TEMPERATURE SENSITIVITY; THERMODYNAMICS;

ANIMALS; CATALYTIC DOMAIN; ENZYME STABILITY; HEAT; HYDROGEN-ION CONCENTRATION; HYDROLYSIS; KINETICS; PEPTIDE FRAGMENTS; PROTEIN BINDING; PROTEIN DENATURATION; PROTEIN FOLDING; PYROCOCCUS FURIOSUS; RECOMBINANT PROTEINS; SERINE ENDOPEPTIDASES; SWINE;

PYROCOCCUS FURIOSUS;

EID: 35449003305     PISSN: 08873585     EISSN: 10970134     Source Type: Journal    
DOI: 10.1002/prot.21522     Document Type: Article

References (39)

1. Rawlings ND, Barrett AJ. Families of serine peptidases. Methods Enzymol 1994;244:19-61.
2. Polgár L. The prolyl oligopeptidase family. Cell Mol Life Sci 2002;59:349-362.
3. Williams RS, Cheng L, Mudge AW, Harwood AJ. A common mechanism of action for three mood-stabilizing drugs. Nature 2002;417: 292-295.
4. Schulz I, Gerhartz B, Neubauer A, Holloschi A, Heiser U, Hafner M, Demuth HU. Modulation of inositol 1,4,5-triphosphate concentration by prolyl endopeptidase inhibition. Eur J Biochem 2002; 269:5813-5820.
5. Cheng L, Lumb M, Polgar L, Mudge AW. How can the mood stabilizer VPA limit both mania and depression? Mol Cell Neurosci 2005;29:155-161.
6. Yoshimoto T, Kado K, Matsubara F, Koriyama N, Kaneto H, Tsura D. Specific inhibitors for prolyl endopeptidase and their anti-amnesic effect. J Pharmacobiodyn 1987;10:730-735.
7. Atack JR, Suman-Chauhan N, Dawson G, Kulagowski JJ. In vitro and in vivo inhibition of prolyl endopeptidase. Eur J Pharmacol 1991;205:157-163.
8. Miura N, Shibata S, Watanabe S. Increase in the septal vasopressin content by prolyl endopeptidase inhibitors in rats. Neurosci Lett 1995;196:128-130.
9. Portevin B, Benoist A, Remond G, Herve Y, Vincent M, Lepagnol J, De Nanteuil G. New prolyl endopeptidase inhibitors: in vitro and in vivo activities of azabicyclo[2.2.2]octane, azabicyclo[2.2.1]heptane, and perhydroindole derivatives. J Med Chem 1996;39:2379-2391.
10. Morain P, Robin JL, De Nanteuil G, Jochemsen R, Heidet V, Guez D. Pharmacodynamic and pharmacokinetic profile of S 17092, a new orally active prolyl endopeptidase inhibitor, in elderly healthy volunteers. A phase I study. Br J Clin Pharmacol 2000;50:350-359.
11. Morain P, Lestage P, De Nanteuil G, Jochemsen R, Robin JL, Guez D, Boyer PA. S 17092: a prolyl endopeptidase inhibitor as a potential therapeutic drug for memory impairment. Preclinical and clinical studies. CNS Drug Rev 2002;8:31-52.
12. Bellemere G, Morain P, Vaudry H, Jegou S. Effect of S 17092, a novel prolyl endopeptidase inhibitor, on substance P and alpha-melanocyte-stimulating hormone breakdown in the rat brain. J Neurochem 2003;84:919-929.
13. Welches WR, Brosnihan KB, Ferrario CM. A comparison of the properties and enzymatic activities of three angiotensin processing enzymes: angiotensin converting enzyme, prolyl endopeptidase and neutral endopeptidase 24.11. Life Sci 1993;52:1461-1480.
14. Shan L, Molberg O, Parrot I, Hausch F, Filiz F, Gray GM, Sollid LM, Khosla C. Structural basis for gluten intolerance in celiac sprue. Science 2002;297:2275-2279.
15. Shan L, Marti T, Sollid LM, Gray GM, Khosla C. Comparative biochemical analysis of three bacterial prolyl endopeptidases: implications for coeliac sprue. Biochem J 2004;383(Pt 2):311-318.
16. Fülöp V, Böcskei Z, Polgár L. Prolyl oligopeptidase: an unusual beta-propeller domain regulates proteolysis. Cell 1998;94:161-170.
17. Szeltner Z, Rea D, Juhász T, Renner V, Fülöp V, Polgár L. Concerted structural changes in the peptidase and the propeller domains of prolyl oligopeptidase are required for substrate binding. J Mol Biol 2004;340:627-637.
18. Harris MN, Madura JD, Ming LJ, Harwood VJ. Kinetic and mechanistic studies of prolyl oligopeptidase from the hyperthermophile Pyrococcus furiosus. J Biol Chem 2001;276:19310-19317.
19. Fuxreiter M, Magyar C, Juhász T, Szeltner Z, Polgár L, Simon I. Flexibility of prolyl oligopeptidase: molecular dynamics and molecular framework analysis of the potential substrate pathways. Proteins 2005;60:504-512.
20. Juhász T, Szeltner Z, Fülöp V, Polgár L. Unclosed beta-propellers display stable structures: implications for substrate access to the active site of prolyl oligopeptidase. J Mol Biol 2005;346:907-917.
21. Shan L, Mathews II, Khosla C. Structural and mechanistic analysis of two prolyl endopeptidases: role of interdomain dynamics in catalysis and specificity. Proc Natl Acad Sci USA 2005;102:3599-3604.
22. Parvari R, Gonen Y, Alshafee I, Buriakovsky S, Regev K, Hershkovitz E. The 2p21 deletion syndrome: characterization of the transcription content. Genomics 2005;86:195-211.
23. Jaeken J, Martens K, Francois I, Eyskens F, Lecointre C, Derua R, Meulemans S, Slootstra JW, Waelkens E, de Zegher F, Creemers JW, Matthijs G. Deletion of PREPL, a gene encoding a putative serine oligopeptidase, in patients with hypotonia-cystinuria syndrome. Am J Hum Genet 2006;78:38-51.
24. Szeltner Z, Alshafee I, Juhász T, Parvari R, Polgár L The PREPL A protein, a new member of the prolyl oligopeptidase family, lacking catalytic activity. Cell Mol Life Sci 2005;62:2376-2381.
25. Szeltner Z, Renner V, Polgár L. Substrate- and pH-dependent contribution of oxyanion binding site to the catalysis of prolyl oligopeptidase, a paradigm of the serine oligopeptidase family. Protein Sci 2000;9:353-360.
26. Juhász T, Szeltner Z, Polgár L. Properties of the prolyl oligopeptidase homologue from Pyrococcus furiosus. FEBS Lett 2006;580: 3493-3497.
27. Szeltner Z, Renner V, Polgár L. The noncatalytic beta-propeller domain of prolyl oligopeptidase enhances the catalytic capability of the peptidase domain. J Biol Chem 2000;275:15000-15005.
28. Ellman GL. Tissue sulfhydryl groups. Arch Biochem Biophys 1959; 82:70-77.
29. Leatherbarrow RJ. Grafit, Version 5.0, Erithacus Software Ltd, Horley, UK. 2001.
30. Vindigni A, Di Cera E. Release of fibrinopeptides by the slow and fast forms of thrombin. Biochemistry 1996;35:4417-4426.
31. Ayala YM, Di Cera E. A simple method for the determination of individual rate constants for substrate hydrolysis by serine proteases. Protein Sci 2000;9:1589-1593.
32. Cleland WW. Determining the chemical mechanisms of enzyme-catalyzed reactions by kinetic studies. Adv Enzymol Relat Areas Mol Biol 1977;45:273-387.
33. Sreerama N, Woody RW. Estimation of protein secondary structure from circular dichroism spectra: comparison of CONTIN, SELCON, and CDSSTR methods with an expanded reference set. Anal Biochem 2000;287:252-260.
34. Blanchard JS. Buffers for enzymes. Methods Enzymol 1984;104:404-414.
35. Zerner B, Bond RPM, Bender ML. Kinetic evidence for the formation of acyl-enzyme intermediates in the alpha-chymotrypsin-catalyzed hydrolyses of specific substrates. J Am Chem Soc 1964;86: 3669-3674.
36. Polgár L. Prolyl endopeptidase catalysis. A physical rather than a chemical step is rate-limiting. Biochem J 1992;283(Pt 3):647-648.
37. Szeltner Z, Rea D, Renner V, Fülöp V, Polgár L. Electrostatic effects and binding determinants in the catalysis of prolyl oligopeptidase. Site specific mutagenesis at the oxyanion binding site. J Biol Chem 2002;277:42613-42622.
38. Fink AL. Compact intermediate states in protein folding. Annu Rev Biophys Biomol Struct 1995;24:495-522.
39. Polgár L, Kollat E, Hollosi M. Prolyl oligopeptidase catalysis. Reactions with thiono substrates reveal substrate-induced conformational change to be the rate-limiting step. FEBS Lett 1993;322:227-230.